HKD 0.6
(0.0%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 14.39 Million CNY | 8.33% |
2022 | 441.54 Million CNY | -13.96% |
2021 | 513.21 Million CNY | 43.46% |
2020 | 357.75 Million CNY | 7.38% |
2019 | 333.15 Million CNY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 69.38 Million CNY | -40.89% |
2024 Q2 | 69.38 Million CNY | 0.0% |
2023 Q1 | 123.88 Million CNY | 8.27% |
2023 FY | 478.3 Million CNY | 8.33% |
2023 Q4 | 117.37 Million CNY | 2.52% |
2023 Q3 | 114.49 Million HKD | -7.58% |
2023 Q2 | 123.88 Million CNY | 0.0% |
2022 Q2 | 102.2 Million CNY | 0.0% |
2022 Q1 | 102.2 Million CNY | -71.71% |
2022 FY | 441.54 Million CNY | -13.96% |
2022 Q4 | 114.41 Million CNY | 0.0% |
2022 Q3 | 114.41 Million CNY | 11.95% |
2021 Q3 | 361.28 Million CNY | 115.22% |
2021 Q4 | 361.28 Million CNY | 0.0% |
2021 Q2 | 167.86 Million CNY | 137.44% |
2021 Q1 | 70.7 Million CNY | -32.98% |
2021 FY | 513.21 Million CNY | 43.46% |
2020 Q1 | 40 Million CNY | 0.0% |
2020 FY | 357.75 Million CNY | 7.38% |
2020 Q4 | 105.49 Million CNY | 0.0% |
2020 Q3 | 105.49 Million CNY | 30.77% |
2020 Q2 | 80.66 Million CNY | 101.67% |
2019 FY | 333.15 Million CNY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Uni-Bio Science Group Limited | 325.05 Million HKD | 95.571% |
CK Life Sciences Int'l., (Holdings) Inc. | 739.25 Million HKD | 98.052% |